Adjuvia Therapeutics: SeedDeveloping therapeutics to treat mitochondrial dysfunction and diseaseOct 4, 2026RoundOSAdjuvia TherapeuticsCompany profile and funding historySourcesbusinesswire.comMore in BiotechAusperBio · Series CProFound Therapeutics · StrategicTransfyr · SeedBiotechUnited StatesHealthtechNorth AmericaSeed